We are live on ! Find out more
CRVS icon

Corvus Pharmaceuticals

47 hedge funds and large institutions have $31.9M invested in Corvus Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more call options, than puts

Call options by funds: $79K | Put options by funds: $73K

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

2% less funds holding

Funds holding: 4847 (-1)

3.15% less ownership

Funds ownership: 39.65%36.5% (-3.1%)

7% less capital invested

Capital invested by funds: $34.2M → $31.9M (-$2.36M)

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8

29% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 14

Holders
47
Holders Change
-1
Holders Change %
-2.08%
% of All Funds
0.68%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
7
Increased
10
Reduced
14
Closed
8
Calls
$79K
Puts
$73K
Net Calls
+$6K
Net Calls Change
+$77K
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of New York Mellon
51
Bank of New York Mellon
New York
-$37.3K -21,219 Closed
Citadel Advisors
52
Citadel Advisors
Florida
-$16K -7,654 Closed
N
53
Natixis
France
-$1.41K -800 Closed
Bank of America
54
Bank of America
North Carolina
-$39 -22 Closed